Adrenoceptor subclassification: an approach to improved cardiovascular therapeutics
- 1 March 2000
- journal article
- review article
- Published by Elsevier in Pharmaceutica Acta Helvetiae
- Vol. 74 (2-3) , 163-171
- https://doi.org/10.1016/s0031-6865(99)00030-8
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- Characterization of postjunctional α-adrenoceptors in the pithed mouseGeneral Pharmacology: The Vascular System, 1999
- Evaluation of Intrinsic Sympathomimetic Activity of Bucindolol and Carvedilol in Rat HeartPharmacology, 1998
- Clinical comparison of selective and non‐selective &agr;1A‐adrenoreceptor antagonists in benign prostatic hyperplasia: studies on tamsulosin in a fixed dose and terazosin in increasing dosesBritish Journal of Urology, 1997
- TamsulosinDrugs, 1996
- Antisense technology reveals the alpha2A adrenoceptor to be the subtype mediating the hypnotic response to the highly selective agonist, dexmedetomidine, in the locus coeruleus of the rat.Journal of Clinical Investigation, 1996
- The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart FailureNew England Journal of Medicine, 1996
- Alpha-Blockade in the Treatment of Symptomatic Benign Prostatic HyperplasiaJournal of Urology, 1995
- Is there a third heart β-adrenoceptor?Trends in Pharmacological Sciences, 1989
- Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart FailureNew England Journal of Medicine, 1986
- Differentiation of Receptor Systems activated by Sympathomimetic AminesNature, 1967